Program Overview

Activity Description Objectives

Target Audience Method of Participation

Term of Approval Acknowledgement of Support

Activity Description

This educational web conference is intended to support clinicians in the practical application of comparative effectiveness research specifically in the context of underserved populations. Demonstrating best practices in action, the web conference presenters will describe effective strategies for improving care using evidence from AHRQ's comparative effectiveness studies on medications for adults with type 2 diabetes mellitus.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

• Apply evidence from the AHRQ's comparative effectiveness research in oral and insulin analogues to improve care for underserved patients with type 2 diabetes mellitus
• Demonstrate effective strategies to address low health literacy and cultural communication barriers among underserved patients with type 2 diabetes
• Identify resources that are available to assist clinicians and patients to improve decision-making in underserved patients with type 2 diabetes

Target Audience

This CME activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, pharmacists and nurses.

Method of Participation

To receive a certificate for this activity, you should:

• Complete the learner assessment pretest
• Attend the online webconference on December 7, 2011 at 1:00 PM EST
• Complete an online evaluation & post-test
• Print your certificate online

The estimated time to complete this activity, including review of the materials, is 1.0 hour.

Term of Approval

December 07, 2011 through December 08, 2012. Original release date: December 07, 2011

Acknowledgement of Support

There is no fee for this CME/CE activity. This activity is sponsored by PRIME Education, Inc (PRIME^®) and funded under contract HHSA290201000006G from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).

Faculty Biographies and Disclosures

Register to Attend

Accreditation/Credit Designation

Physician Credit Designation Statement

PRIME Education, Inc. (PRIME^®) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

PRIME^® designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

AAPA accepts AMA Category 1 CME Credit^™ for the PRA from organizations accredited by ACCME.

Nurse Practitioner Accreditation Statement

PRIME Education, Inc. (PRIME^®) is accredited by the American Academy of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This program is accredited for 1.0 contact hour. Program ID# CER14.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

Pharmacist Accreditation Statement

This curriculum has been approved for 1.0 contact hour by PRIME^®. PRIME^® is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this program is 0255-0000-11-028-L01-P. This learning activity is Knowledge-Based.

Nurse Accreditation Statement

PRIME Education, Inc. (PRIME^®) is an Approved Provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

PRIME^® designates this activity for 1.0 contact hour.

Register to Attend

Faculty Disclosures

Disclosure Policy

PRIME Education Inc (PRIME^®) endorses the standards of the ACCME, as well as those of the AANP, ANCC and ACPE, that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

Aconflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

PRIME willidentify, review and resolve all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. Disclosure information for speakers, authors, course directors, planners, peer reviewers, and/or relevant staff are provided with this activity.

Presentations that provide information in whole or in part related to non FDA approved uses of drugs and/or devices will disclose the unlabeled indications or the investigational nature of their proposed uses to the audience. Participants should refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. Participants should verify all information and data before treating patients or employing any therapies prescribed in this educational activity. The opinions expressed in the educational activity are those of the presenting faculty and do not necessarily represent the views of PRIME^®, the ACCME, AANP, ACPE, ANCC and other relevant accreditation bodies.

Content validation methods are consistently utilized by PRIME to ensure that all program content is evidence-based, fair-balanced, and developed with scientific rigor and integrity. All clinical recommendations are based on evidence accepted within the medical profession. All scientific research referred to, reported or used to support a clinical recommendation conforms to accepted standards of experimental design, data collection and analysis. In addition to review of content by course directors and expert faculty, content is also validated through independent peer reviewers selected for their expertise in the content area, as well as their experience in the intended audience. All peer reviewers, planners, course directors, faculty and relevant staff utilized by PRIME complete disclosures which are related to their role in the educational activity.

Accessibility

PRIME^®is committed to providing access to our CME programs for individuals with disabilities as identified in Section 508 of the Rehabilitation Act for all web-based programs. This website is 508 compliant.

Register to Attend

Post-Test & Evaluation

You must access the activity before receiving credit!